Aflac Tops Q4 EPS by 8c
- ByInvesting.com-
Aflac (AFL) reported Q4 EPS of $1.29, $0.08 better than the analyst estimate of $1.21. Revenue for the quarter came in at $4.01 billion versus the consensus estimate of $4.49...
Symbol | Exchange | Currency |
|---|
Aflac (AFL) reported Q4 EPS of $1.29, $0.08 better than the analyst estimate of $1.21. Revenue for the quarter came in at $4.01 billion versus the consensus estimate of $4.49...
Investing.com - Aflac (NYSE: AFL) reported fourth quarter EPS of $1.29, $0.08 better than the analyst estimate of $1.21. Revenue for the quarter came in at $4.01B versus the...
After Big Tech and Big Oil stocks reported earnings this week, next week’s lineup will continue to feature a few well-known names among their respective sectors. Let’s take a look...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
The Federal Reserve is widely expected to deliver its first interest rate hike since December 2018 at the conclusion of its policy meeting on Wednesday, with a 25 basis point...
Aflac Incorporated is a holding company engaged in the supplemental health and life insurance business. The Company's insurance business is marketed and administered through, American Family Life Assurance Company of Columbus (Aflac) in the United States and through Aflac Life Insurance Japan Ltd. (ALIJ) in Japan. The Company's segments include Aflac Japan and Aflac U.S. Aflac Japan is designed to help consumers pay for medical and non-medical costs that are not reimbursed under Japan's national health insurance system. It offers insurance products, such as cancer, medical, and income support insurance. Its protection products include Medical Insurance, Nursing Care Insurance, Income Support Insurance, whole life, GIFT, WAYS and Child Endowment. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. products are distributed in the individual and group supplemental insurance markets.
| Average | 70.58 (+1.72% Upside) |
| High | 80.00 |
| Low | 57.00 |
| Price | 69.39 |
| No. of Analysts | 12 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Sell | Sell | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Sell | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 6.79 | 6.81 | 6.79 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 60.33 | 60.40 | 59.15 | +1.10 | +1.86% | 1.78M | Toronto | |||
| 1.22 | 1.27 | 1.21 | -0.05 | -3.94% | 279.18K | Toronto | |||
| 66.24 | 66.24 | 65.55 | -0.16 | -0.24% | 1.13K | Toronto | |||
| 0.53 | 0.55 | 0.53 | -0.0100 | -1.85% | 196.50K | TSXV | |||
| 0.075 | 0.08 | 0.075 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 0.015 | 0.02 | 0.015 | 0.00 | 0.00% | 47.40K | CSE | |||
| 0.165 | 0.165 | 0.165 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 4.98 | 4.98 | 4.97 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 13.61 | 13.69 | 13.54 | +0.02 | +0.15% | 159.34K | Toronto | |||
| 9.71 | 9.71 | 9.70 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 0.12 | 0.12 | 0.10 | 0.00 | 0.00% | 365.72K | TSXV | |||
| 0.41 | 0.45 | 0.40 | +0.005 | +1.23% | 72.34K | CSE | |||
| 0.04 | 0.04 | 0.04 | -0.005 | -11.11% | 15.70K | CSE | |||
| 18.26 | 18.26 | 18.26 | -0.15 | -0.81% | 100.00 | Toronto |